Smith & Nephew SNATS Operating Income 2010-2023 | SNN
- Smith & Nephew SNATS operating income for the quarter ending December 31, 2023 was $M, a NAN% increase year-over-year.
- Smith & Nephew SNATS operating income for the twelve months ending December 31, 2023 was $0M, a NAN% increase year-over-year.
- Smith & Nephew SNATS annual operating income for 2023 was $0.425B, a 5.56% decline from 2022.
- Smith & Nephew SNATS annual operating income for 2022 was $0.45B, a 24.11% decline from 2021.
- Smith & Nephew SNATS annual operating income for 2021 was $0.593B, a 101.02% increase from 2020.
Smith & Nephew SNATS Annual Operating Income (Millions of US $) |
|
---|---|
2023 | $425 |
2022 | $450 |
2021 | $593 |
2020 | $295 |
2019 | $815 |
2018 | $863 |
2017 | $934 |
2016 | $801 |
2015 | $628 |
2014 | $749 |
2013 | $810 |
2012 | $846 |
2011 | $862 |
2010 | $920 |
2009 | $723 |
Smith & Nephew SNATS Quarterly Operating Income (Millions of US $) |
|
---|---|
2023-12-31 | |
2023-06-30 | |
2022-12-31 | |
2022-06-30 | |
2021-12-31 | |
2021-06-30 | |
2020-12-31 | |
2020-06-30 | |
2019-12-31 | |
2019-06-30 | |
2018-12-31 | |
2018-06-30 | |
2017-12-31 | |
2017-06-30 | |
2016-12-31 | |
2015-12-31 | |
2015-06-30 | |
2014-12-31 | $226 |
2014-09-30 | $160 |
2014-06-30 | $134 |
2014-03-31 | $229 |
2013-12-31 | $235 |
2013-09-30 | $180 |
2013-06-30 | $188 |
2013-03-31 | $207 |
2012-12-31 | $213 |
2012-09-30 | $187 |
2012-06-30 | $210 |
2012-03-31 | $236 |
2011-12-31 | $214 |
2011-09-30 | $191 |
2011-06-30 | $226 |
2011-03-31 | $231 |
2010-12-31 | $267 |
2010-09-30 | $206 |
2010-06-30 | $207 |
2010-03-31 | $240 |
2009-12-31 | $189 |
2009-09-30 | $186 |
2009-06-30 | $189 |
2009-03-31 | $159 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $10.422B | $5.549B |
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $186.151B | 24.44 |
Stryker (SYK) | United States | $123.816B | 30.70 |
Medtronic (MDT) | Ireland | $105.535B | 14.94 |
Boston Scientific (BSX) | United States | $98.780B | 32.84 |
EssilorLuxottica (ESLOY) | France | $98.612B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $41.070B | 0.00 |
Haleon (HLN) | United Kingdom | $37.534B | 29.36 |
ResMed (RMD) | United States | $26.307B | 26.30 |
Zimmer Biomet Holdings (ZBH) | United States | $24.538B | 15.80 |
Terumo (TRUMY) | Japan | $24.492B | 34.59 |
Baxter (BAX) | United States | $20.044B | 14.62 |
Koninklijke Philips (PHG) | Netherlands | $18.554B | 14.80 |
Insulet (PODD) | United States | $11.641B | 61.12 |
Demant (WILYY) | Denmark | $9.965B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.977B | 23.77 |
BellRing Brands (BRBR) | United States | $7.070B | 38.01 |
Lantheus Holdings (LNTH) | United States | $4.374B | 11.29 |
Perrigo (PRGO) | Ireland | $4.174B | 11.94 |
Haemonetics (HAE) | United States | $4.126B | 21.10 |
GN Store Nord (GNNDY) | Denmark | $3.707B | 24.00 |
Prestige Consumer Healthcare (PBH) | United States | $3.459B | 16.35 |
Envista Holdings (NVST) | United States | $3.430B | 13.05 |
QuidelOrtho (QDEL) | United States | $2.616B | 9.50 |
Green Thumb Industries (GTBIF) | United States | $2.602B | 82.47 |
Neogen (NEOG) | United States | $2.515B | 24.19 |
ICU Medical (ICUI) | United States | $2.333B | 17.41 |
TG Therapeutics (TGTX) | United States | $2.130B | 689.00 |
Owens & Minor (OMI) | United States | $1.899B | 18.23 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.835B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.710B | 0.00 |
Agios Pharmaceuticals (AGIO) | United States | $1.659B | 0.00 |
National Vision Holdings (EYE) | United States | $1.471B | 45.81 |
InMode (INMD) | Israel | $1.462B | 7.57 |
LeMaitre Vascular (LMAT) | United States | $1.420B | 46.86 |
AdaptHealth (AHCO) | United States | $1.241B | 9.34 |
Warby Parker (WRBY) | United States | $1.185B | 0.00 |
AtriCure (ATRC) | United States | $1.122B | 0.00 |
MacroGenics (MGNX) | United States | $0.977B | 0.00 |
Canopy Growth (CGC) | Canada | $0.723B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.718B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.691B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.690B | 14.90 |
Evolus (EOLS) | United States | $0.668B | 0.00 |
Quanterix (QTRX) | United States | $0.605B | 0.00 |
Jin Medical (ZJYL) | China | $0.600B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.539B | 11.67 |
Valneva SE (VALN) | France | $0.528B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.481B | 0.00 |
PetIQ (PETQ) | United States | $0.479B | 17.89 |
ZimVie (ZIMV) | United States | $0.420B | 25.72 |
Biote (BTMD) | United States | $0.413B | 3.93 |
OraSure Technologies (OSUR) | United States | $0.404B | 6.68 |
Surmodics (SRDX) | United States | $0.377B | 40.75 |
Zynex (ZYXI) | United States | $0.366B | 42.15 |
Aurora Cannabis (ACB) | Canada | $0.352B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.305B | 30.31 |
Cerus (CERS) | United States | $0.305B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.291B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.254B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.246B | 15.01 |
Organigram Holdings (OGI) | Canada | $0.195B | 0.00 |
Veru (VERU) | United States | $0.192B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.180B | 0.00 |
High Tide (HITI) | Canada | $0.179B | 0.00 |
Omeros (OMER) | United States | $0.177B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.158B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.147B | 0.00 |
FitLife Brands (FTLF) | United States | $0.133B | 21.39 |
Eagleford Energy (GRUSF) | United States | $0.126B | 63.55 |
Jushi Holdings (JUSHF) | United States | $0.125B | 0.00 |
InterCure (INCR) | Israel | $0.115B | 19.46 |
Fonar (FONR) | United States | $0.106B | 9.14 |
MariMed (MRMD) | United States | $0.101B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.098B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.095B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
Safety Shot (SHOT) | United States | $0.091B | 0.00 |
Brainsway (BWAY) | Israel | $0.081B | 0.00 |
Chimerix (CMRX) | United States | $0.079B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.071B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.060B | 3.91 |
United Health Products (UEEC) | United States | $0.050B | 0.00 |
Apyx Medical (APYX) | United States | $0.046B | 0.00 |
Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
Bright Green (BGXX) | United States | $0.040B | 0.00 |
ImmuCell (ICCC) | United States | $0.039B | 0.00 |
United-Guardian (UG) | United States | $0.037B | 14.30 |
Modular Medical (MODD) | United States | $0.036B | 0.00 |
Exagen (XGN) | United States | $0.024B | 0.00 |
Nephros (NEPH) | United States | $0.022B | 0.00 |
GlucoTrack (GCTK) | United States | $0.022B | 0.00 |
Agape ATP (ATPC) | $0.019B | 0.00 | |
FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
Flora Growth (FLGC) | United States | $0.017B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 72.64 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |